Results
1
-
10
of
118
<
1
2
3
...
11
12
>
Hoffmann F; Glaeske G.
[Benzodiazepine hypnotics, zolpidem and zopiclone on private prescriptions: use between 1993 and 2012].
,
Der Nervenarzt
[PubMed: 24663439]
[DOI: 10.1007/s00115-014-4016-8]
Victorri-Vigneau C; Feuillet F; Wainstein L; Grall-Bronnec M; Pivette J; Chaslerie A; S?bille V; Jolliet P.
Pharmacoepidemiological characterisation of zolpidem and zopiclone usage.
,
European journal of clinical pharmacology
[PubMed: 23877252]
[DOI: 10.1007/s00228-013-1557-x]
Gunja N.
In the Zzz zone: the effects of Z-drugs on human performance and driving.
,
Journal of medical toxicology : official journal of the American College of Medical Toxicology
[PubMed: 23456542]
[DOI: 10.1007/s13181-013-0294-y]
Gunja N.
The clinical and forensic toxicology of Z-drugs.
,
Journal of medical toxicology : official journal of the American College of Medical Toxicology
[PubMed: 23404347]
[DOI: 10.1007/s13181-013-0292-0]
Bocca ML; Marie S; Lelong-Boulouard V; Denise P; Bertran F; Couque C; Desfemmes T; Berthelon C; Amato JN; Moessinger M; Paillet-Loilier M; Coquerel A.
Zolpidem and zopiclone impair similarly monotonous driving performance after a single nighttime intake in aged subjects.
,
Psychopharmacology
[PubMed: 21086117]
[DOI: 10.1007/s00213-010-2075-5]
Xi M; Chase MH.
The impact of age on the hypnotic effects of eszopiclone and zolpidem in the guinea pig.
,
Psychopharmacology
[PubMed: 19343329]
[DOI: 10.1007/s00213-009-1520-9]
Hoffmann F; Scharffetter W; Glaeske G.
[Use of zolpidem and zopiclone on private prescriptions between 1993 and 2007].
,
Der Nervenarzt
[PubMed: 19169658]
[DOI: 10.1007/s00115-008-2648-2]
Hoffmann F; Pfannkuche M; Glaeske G.
[High usage of zolpidem and zopiclone. Cross-sectional study using claims data].
,
Der Nervenarzt
[PubMed: 17457554]
[DOI: 10.1007/s00115-007-2280-6]
Allain H; Bentu?-Ferrer D; Tarral A; Gandon JM.
Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo.
,
European journal of clinical pharmacology
[PubMed: 12756510]
[DOI: 10.1007/s00228-003-0591-5]
Tornio A; Neuvonen PJ; Backman JT.
The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopiclone.
,
European journal of clinical pharmacology
[DOI: 10.1007/s00228-006-0155-6]
<
1
2
3
...
11
12
>